Although South Korean pharma companies may not have the unique open and external innovation platforms of global pharma firms, they have nevertheless been accumulating their own experience and know-how in recent years, to devise R&D strategies that meet their needs and are suitable for their particular situations.
Pharma companies in the country have been more aggressively making strategic investments in bioventures and in new drug R&D in...